RoHS II Gathers Momentum – European Parliament Completes First Reading on Draft

RoHS II Gathers Momentum – European Parliament Completes First Reading on Draft

The European Parliament completed its first reading of the draft of RoHS II in November 2010. Items that were previously in question have now been clarified and RoHS II is on its way to becoming a CE Mark directive. No new restricted substances have been introduced and the publication of the directive is expected in the first quarter of this year.

Using Roche-s CASY Cell Counter and Analyzer for proliferation and viability measurement in cancer studies

In a recent study (1), Prokop et al. used the CASY Cell Counter and Analyzer from Roche Applied Science (SIX: RO, ROG; OTCQX: RHHBY) to identify the specific anticancer properties of a therapeutic substance in Burkitt-like lymphoma cells (BJAB cells). In addition to using the CASY system for multi-parameter quality control of the cell cultures, the team also brought the system to bear in examining apoptosis induction as early as 24 hours after treatment, i.e., before taking final measurements w